Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
MA1-10762 detects Procainamide.
MA1-10762 has been successfully used in ELISA applications.
The MA1-10762 immunogen is Procainamide, conjugated to KLH.
Procainamide is an oral antiarrhythmic agent that has been in wide use for more than 60 years. Long term procainamide therapy is known to induce hypersensitivity reactions, autoantibody formation and a lupus-like syndrome but is a rare cause of clinically apparent acute liver injury. [National Center for Biotechnology Information. PubChem Compound Database; CID=4913].
仅用于科研。不用于诊断过程。未经明确授权不得转售。